video-assisted thoracoscopic surgery postoperative Depression
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18-65 Patients undergoing unilateral VATS surgery due to pulmonary nodules under general anesthesia ASA II-III stage The patient is conscious and normal, has no expression disorder, and is capable of cooperating with treatment and signing informed consent
Exclusion criteria
Exclusion criteria: Combined with acupoint local skin infection Patients with upper extremity nerve injury Patients with an implanted pacemaker Alcoholics and long-term users of opioids, hormones, anti-inflammatory and analgesic drugs Allergic to the drug used in the trial Have recently undergone TAES or acupoint therapy A history of mental illness or ongoing use of psychotropic drugs People being treated with monoamine oxidase (MAO) inhibitors Patients with severe diseases of heart, brain, liver, kidney and hematopoietic system Patients who were unable to cooperate with the study for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Beck depression inventory score 30 days after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep NRS score 2 days after surgery;Dosage of patient-controlled intravenous analgesia 48h after operation;Dosage of patient-controlled intravenous analgesia 24h after operation;Beck depression inventory score 2 days after surgery;Serum tumor necrosis factor-a concentration 2 days after surgery;Serum interleukin-6 concentration 2 days after surgery;24h postoperative resting pain score;48h postoperative moving pain score;48h postoperative resting pain score;TAES Related complications;24h postoperative moving pain score; | — |
Countries
China
Contacts
Fuling Hospital Affiliated to Chongqing University